English Polski
Vol 26, No 4 (2020)
Case report
Published online: 2021-03-22

open access

Page views 703
Article views/downloads 944
Get Citation

Connect on Social Media

Connect on Social Media

Primary intestinal lymphangiectasia with lymphedema of lower extremities

Kamil Klimas1, Katarzyna Drożdż1, Angelika Chachaj1, Andrzej Szuba1
Acta Angiologica 2020;26(4):140-143.

Abstract

Primary intestinal lymphangiectasia (PIL), also known as Waldmann’s disease, is a rare disorder manifested
by the presence of dilated intestinal lymphatic ducts and leading to protein-losing enteropathy. PIL usually
presents early in childhood; however, rarely may be also diagnosed in adults. Suggestive laboratory findings
include hypoproteinemia, hypoalbuminemia, and hypogammaglobulinemia. Peripheral pitting edema due to
hypoalbuminemia is the main clinical feature. Peripheral lymphedema is a less common symptom. We present
a case of a 23-year-old woman with lymphedema of lower extremities and PIL diagnosed in childhood.

Article available in PDF format

View PDF Download PDF file

References

  1. Vignes S, Bellanger J. Primary intestinal lymphangiectasia (Waldmann's disease). Orphanet J Rare Dis. 2008; 3: 5.
  2. Ingle SB, Hinge Ingle CR. Primary intestinal lymphangiectasia: Minireview. World J Clin Cases. 2014; 2(10): 528–533.
  3. Lopez RN, Day AS. Primary intestinal lymphangiectasia in children: A review. J Paediatr Child Health. 2020; 56(11): 1719–1723.
  4. Abramowsky C, Hupertz V, Kilbridge P, et al. Intestinal lymphangiectasia in children: a study of upper gastrointestinal endoscopic biopsies. Pediatr Pathol. 1989; 9(3): 289–297.
  5. Lee WS, Boey CC. Chronic diarrhoea in infants and young children: causes, clinical features and outcome. J Paediatr Child Health. 1999; 35(3): 260–263.
  6. Goktan C, Pekindil G, Orguc S, et al. Bilateral breast edema in intestinal lymphangiectasia. Breast J. 2005; 11(5): 360.
  7. Wen J, Tang Q, Wu J, et al. Primary intestinal lymphangiectasia: four case reports and a review of the literature. Dig Dis Sci. 2010; 55(12): 3466–3472.
  8. Lee SJ, Song HJ, Boo SJ, et al. Primary intestinal lymphangiectasia with generalized warts. World J Gastroenterol. 2015; 21(27): 8467–8472.
  9. Maconi G, Molteni P, Manzionna G, et al. Ultrasonographic features of long-standing primary intestinal lymphangiectasia. Eur J Ultrasound. 1998; 7(3): 195–198.
  10. Mazzie J, Maslin P, Moy L, et al. Congenital intestinal lymphangiectasia. Clinical Imaging. 2003; 27(5): 330–332.
  11. Yang DMo, Jung DH. Localized intestinal lymphangiectasia: CT findings. AJR Am J Roentgenol. 2003; 180(1): 213–214.
  12. Sun X, Shen W, Chen X, et al. Primary intestinal lymphangiectasia: Multiple detector computed tomography findings after direct lymphangiography. J Med Imaging Radiat Oncol. 2017; 61(5): 607–613.
  13. Szuba A, Shin WS, Strauss HW, et al. The third circulation: radionuclide lymphoscintigraphy in the evaluation of lymphedema. J Nucl Med. 2003; 44(1): 43–57.
  14. Prasad D, Srivastava A, Tambe A, et al. Clinical Profile, Response to Therapy, and Outcome of Children with Primary Intestinal Lymphangiectasia. Dig Dis. 2019; 37(6): 458–466.
  15. Sari S, Baris Z, Dalgic B. Primary intestinal lymphangiectasia in children: is octreotide an effective and safe option in the treatment? J Pediatr Gastroenterol Nutr. 2010; 51(4): 454–457.
  16. Chen CP, Chao Y, Li CP, et al. Surgical resection of duodenal lymphangiectasia: a case report. World J Gastroenterol. 2003; 9(12): 2880–2882.
  17. Hammill AM, Wentzel M, Gupta A, et al. Sirolimus for the treatment of complicated vascular anomalies in children. Pediatr Blood Cancer. 2011; 57(6): 1018–1024.
  18. Ozeki M, Hori T, Kanda K, et al. Everolimus for Primary Intestinal Lymphangiectasia With Protein-Losing Enteropathy. Pediatrics. 2016; 137(3): e20152562.
  19. Szuba A, Rockson SG. Lymphedema: classification, diagnosis and therapy. Vasc Med. 1998; 3(2): 145–156.